Iveric Bio Inc (ISEE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2017 | 12-2016 | 12-2015 | 12-2014 | 12-2013 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 114,205 | -193,420 | -105,717 | -116,772 | -51,145 |
| Depreciation Amortization | 2,903 | 1,352 | 3,546 | 2,151 | 108 |
| Income taxes - deferred | -3,366 | 22,954 | -17,341 | -214 | N/A |
| Accounts payable and accrued liabilities | -4,481 | 14 | 3,311 | 4,897 | 2,417 |
| Other Working Capital | -257,265 | 28,000 | 21,011 | 218,099 | -2,968 |
| Other Operating Activity | 26,183 | 32,504 | 16,659 | 2,927 | 2,813 |
| Operating Cash Flow | $-121,821 | $-108,596 | $-78,531 | $111,088 | $-48,775 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | -572 | -2,609 | -1,655 | -5 |
| Purchase Of Investment | -12,014 | -72,197 | -411,565 | -597,762 | N/A |
| Sale Of Investment | 166,806 | 86,500 | 661,977 | 171,600 | N/A |
| Investing Cash Flow | $154,792 | $13,731 | $247,803 | $-427,817 | $-5 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | N/A | N/A | N/A | N/A | -11,900 |
| Common Stock Issued | 71 | 6,934 | 11,473 | 58,358 | 175,649 |
| Other Financing Activity | 0 | 0 | 1,302 | 87,589 | 91,323 |
| Financing Cash Flow | $71 | $6,934 | $12,775 | $145,947 | $255,072 |
| Beginning Cash Position | 133,930 | 221,861 | 39,814 | 210,596 | 4,304 |
| End Cash Position | 166,972 | 133,930 | 221,861 | 39,814 | 210,596 |
| Net Cash Flow | $33,042 | $-87,931 | $182,047 | $-170,782 | $206,292 |
| Free Cash Flow | |||||
| Operating Cash Flow | -121,821 | -108,596 | -78,531 | 111,088 | -48,775 |
| Capital Expenditure | N/A | -572 | -2,615 | -1,655 | -5 |
| Free Cash Flow | -121,821 | -109,168 | -81,146 | 109,433 | -48,780 |